clinical trial · NCT07816692
iDose TR Administration in an Office-Based Surgery Setting
Open Angle Glaucoma (OAG)Ocular Hypertension (OHT)iDose TR (travoprost intracameral implant) 75 µg
brief summary
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
started
May 13, 2026
primary completion
Mar 1, 2027
completion
Mar 1, 2027
last updated
Sep 30, 2026
detailed description
This study is a multicenter, single arm, open-label trial in adult subjects with open-angle glaucoma or ocular hypertension. The objective of the study is to assess the safety profile of iDose TR administration in an office-based surgery setting.
official title
Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol